Iran
06.08.2020 | clinical research
Treating COVID-19 with interfron-beta-1a twice reduces mortality
Subcutaneous administration of interferon three times a week increases the frequency of discharge on day 14 from 44% to 67%
Subcutaneous administration of interferon three times a week increases the frequency of discharge on day 14 from 44% to 67%